Verrica Pharmaceuticals Inc.·4

Mar 18, 6:45 PM ET

Rieger Jayson 4

4 · Verrica Pharmaceuticals Inc. · Filed Mar 18, 2025

Insider Transaction Report

Form 4
Period: 2025-03-14
Rieger Jayson
DirectorCEO and President
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-14+850,000850,000 total
    Exercise: $0.89Exp: 2035-03-14Common Stock (850,000 underlying)
Footnotes (1)
  • [F1]1/8th of the total shares subject to the option shall vest on September 14, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file
  • 4
    form4-03182025_060303.xmlPrimary